Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

President’s Message

Dear ALTG Colleagues,

Earlier this year I explained key targets for ALTG; to progress our clinical trial portfolio, extend the reach of our educational programs and grow our reputation within the lung cancer and Thoracic Oncology space. The ALTG trial portfolio is tracking well with the initiation of two new trials expected before the year’s end; STIMULI and ILLUMINATE. We also have some exciting ALTG educational events next month, and it is my pleasure to invite you to attend. I also wish to recognise our sponsors for their ongoing generosity and commitment to the success of ALTG educational activities.

The first ALTG Speaker’s Tour will be being held in Melbourne on October 2 (visiting overseas speaker DR Bob Li from MSKCC) and Brisbane on October 4 (visiting overseas speaker Dr Sanjay Popat from the Royal Marsden Hospital). The theme of these sessions will be “The Evolving Role of Immunotherapy in the Management of Lung Cancer”. This is a new educational event for ALTG with the goal to reach regional and remote ALTG members that are unable to attend our national events. Both meetings will be chaired by and include excellent local guest speakers, and dinner is provided. I encourage you to take advantage of these meetings and attend a session.
The ALTG Symposium and Members Meeting are around the corner on October 5-6 with a line-up of local and visiting guest speakers who will present perspectives of current, evidence-based research and transitioning evidence into practice. Our goal is to engage multidisciplinary practitioners working across a range of clinical specialities involved in the management of lung cancers. Our annual ALTG Members’ Meeting will precede the ASM followed by welcome reception on the Friday night so mark 5-6 October in your diaries for a trip to Sydney.

I’d like to welcome two new consumer representatives to our Scientific Advisory Committee; Ms Anita McGrath and Ms Rosemary Taylor. Consumer advisors are an essential part of the ALTG trial framework and provide the patient-centric perspective to our trials. We are fortunate to have you both on board!
The 4th ALTG Preceptorship in Lung Cancer was held in August in Melbourne with excellent participation from our delegates and Preceptors. This year’s workshop included for the first time two cancer care nurses and two consumer representatives with the goal to create a multidisciplinary care team perceptive within the group. Following formal feedback we will continue to work on the Lung Cancer Preceptorship model to develop in order to make it the best it can be. See you at the Symposium!


Associate Professor Nick Pavlakis

ALTG President